Thunderbird Partners LLP Purchases 12,857 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Thunderbird Partners LLP raised its position in UnitedHealth Group Incorporated (NYSE:UNH) by 23.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 68,116 shares of the healthcare conglomerate’s stock after buying an additional 12,857 shares during the quarter. UnitedHealth Group accounts for 55.7% of Thunderbird Partners LLP’s holdings, making the stock its biggest holding. Thunderbird Partners LLP’s holdings in UnitedHealth Group were worth $34,457,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of UNH. Howard Capital Management Group LLC acquired a new position in shares of UnitedHealth Group in the 3rd quarter valued at approximately $341,000. Principal Financial Group Inc. boosted its stake in UnitedHealth Group by 11.3% in the third quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate’s stock valued at $1,039,933,000 after buying an additional 180,479 shares in the last quarter. McIlrath & Eck LLC increased its position in UnitedHealth Group by 8.2% during the 3rd quarter. McIlrath & Eck LLC now owns 635 shares of the healthcare conglomerate’s stock worth $371,000 after purchasing an additional 48 shares in the last quarter. SOA Wealth Advisors LLC. boosted its position in UnitedHealth Group by 3.7% in the third quarter. SOA Wealth Advisors LLC. now owns 1,275 shares of the healthcare conglomerate’s stock valued at $746,000 after buying an additional 46 shares in the last quarter. Finally, Tudor Financial Inc. bought a new position in shares of UnitedHealth Group in the 3rd quarter valued at $900,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH opened at $425.39 on Tuesday. The stock has a 50-day moving average of $510.91 and a 200-day moving average of $538.77. The company has a market cap of $389.11 billion, a PE ratio of 27.44, a P/E/G ratio of 1.37 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a one year low of $424.81 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The business had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter in the prior year, the business earned $6.91 earnings per share. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 1.97%. UnitedHealth Group’s dividend payout ratio (DPR) is 35.18%.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on UNH shares. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Mizuho raised their price objective on shares of UnitedHealth Group from $600.00 to $650.00 and gave the company an “outperform” rating in a report on Wednesday, April 9th. Piper Sandler decreased their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective on the stock in a research note on Friday, January 10th. Finally, Raymond James reaffirmed a “strong-buy” rating and set a $540.00 target price (down from $635.00) on shares of UnitedHealth Group in a report on Monday. One equities research analyst has rated the stock with a hold rating, twenty have issued a buy rating and four have issued a strong buy rating to the company’s stock. According to MarketBeat, UnitedHealth Group presently has a consensus rating of “Buy” and an average target price of $615.24.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.